# Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

> **NCT03886181** · NA · TERMINATED · sponsor: **Alpha Tau Medical LTD.** · enrollment: 2 (actual)

## Conditions studied

- Skin Cancer
- Mucosal Neoplasm of Oral Cavity
- Soft Tissue Neoplasm

## Interventions

- **DEVICE:** Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

## Key facts

- **NCT ID:** NCT03886181
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-08
- **Primary completion:** 2024-10-13
- **Final completion:** 2024-10-13
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulties in recruitment and the site's resources to recruit patients
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03886181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03886181, "Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03886181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*